{"gene":"CREM","run_date":"2026-04-28T17:28:53","timeline":{"discoveries":[{"year":1991,"finding":"CREM encodes multiple isoforms generated by cell-specific alternative splicing that use two alternative downstream DNA-binding domains; all isoforms bind CRE sequences with the same efficiency and specificity as CREB but act as transcriptional repressors/antagonists of cAMP-induced transcription rather than activators.","method":"PCR, RNase protection analysis, DNA binding assays, transfection reporter assays","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods in a foundational paper, replicated by subsequent work","pmids":["1847666"],"is_preprint":false},{"year":1992,"finding":"A developmental switch in CREM splicing occurs during spermatogenesis: premeiotic germ cells express CREM antagonist isoforms at low levels, whereas from pachytene spermatocyte stage onwards an alternative splicing event generates exclusively the CREM tau activator isoform (which contains two glutamine-rich activation domains) that accumulates to very high levels.","method":"Northern blot, RT-PCR, transfection reporter assays, cell-type-specific expression analysis","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1-2 — orthogonal methods, replicated across multiple subsequent studies","pmids":["1370576"],"is_preprint":false},{"year":1991,"finding":"CREM antagonists repress cAMP-induced c-fos transcription by binding to the CRE at -60 of the c-fos promoter and heterodimerizing with activator CREB; antisense CREM enhances c-fos basal and cAMP-induced transcription. CREM does not antagonize serum-induced transcription.","method":"Transfection reporter assays, antisense CREM expression, EMSA/competition binding","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods with functional and binding validation","pmids":["1647033"],"is_preprint":false},{"year":1992,"finding":"CREM antagonists bind TRE (AP-1) sites and competitively inhibit c-Jun transcriptional activation without heterodimerizing with Fos or Jun proteins; the phosphorylation domain of CREM is not required for this repression, and the Jun family members JunB, JunD, and v-Jun are also down-regulated.","method":"EMSA, transfection reporter assays, in vitro binding assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods demonstrating mechanism of cross-talk repression","pmids":["1429597"],"is_preprint":false},{"year":1993,"finding":"CREM is inducible by the cAMP signaling pathway from an alternative intronic promoter, generating the ICER (inducible cAMP early repressor) isoform as an early response gene. ICER binds to four tandem CREs in its own (intronic) promoter and represses its own transcription, constituting a negative autoregulatory feedback loop. The subsequent decline in CREM expression requires de novo protein synthesis.","method":"Promoter analysis, transfection reporter assays, Northern blot, protein synthesis inhibition experiments","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods; mechanistically foundational and widely replicated","pmids":["8252624"],"is_preprint":false},{"year":1993,"finding":"FSH (follicle-stimulating hormone) from the pituitary is responsible for the developmental CREM switch from antagonist to activator (CREM tau) during spermatogenesis; hypophysectomy extinguishes CREM tau expression in testis. FSH regulates CREM expression by alternative polyadenylation, resulting in enhanced transcript stability.","method":"Hypophysectomy experiments, seasonal spermatogenesis modulation in hamsters, direct hormone administration, Northern blot, RNase protection","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 — in vivo epistasis via hormone replacement, multiple orthogonal approaches","pmids":["7681549"],"is_preprint":false},{"year":1993,"finding":"CREM tau is phosphorylated at Ser117 by protein kinase A (PKA) endogenous to germ cells, and this phosphorylation enhances its transactivation potential. CREM tau binds to CREs in promoters of postmeiotic germ cell-specific genes (e.g., RT7), and CREM-specific antibodies block RT7 in vitro transcription.","method":"In vitro kinase assays, transfection reporter assays, in vitro transcription with nuclear extracts, antibody supershift/blocking","journal":"Molecular endocrinology (Baltimore, Md.)","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro kinase assay plus in vitro transcription with antibody blocking, multiple orthogonal methods","pmids":["8114765"],"is_preprint":false},{"year":1993,"finding":"The exon structure of the CREM gene was determined; CREM isoforms heterodimerize in vivo with each other and with CREB. The two alternative DNA-binding domains show distinct CRE binding efficiencies (CREM alpha/CREB heterodimers show stronger binding than CREM beta/CREB heterodimers). A phosphorylation domain plus a single glutamine-rich domain are sufficient for transcriptional activation. A minimal CREM repressor containing only the bZip motif efficiently antagonizes cAMP-induced transcription. Phosphorylation reduces repressor function.","method":"Exon mapping, in vivo dimerization assays, EMSA, transfection reporter assays, mutagenesis","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1-2 — structure-function mutagenesis combined with binding and transcription assays","pmids":["8458330"],"is_preprint":false},{"year":1993,"finding":"CREM tau is phosphorylated on multiple serine and threonine residues in vivo. Stimulation by forskolin, TPA, or Ca2+ ionophore enhances Ser117 phosphorylation and transactivation. Casein kinase I and II cooperatively phosphorylate CREM tau on multiple residues, enhancing DNA binding. Multiple kinases can phosphorylate Ser117 in vitro.","method":"In vivo phosphorylation labeling, in vitro kinase assays, EMSA, transfection reporter assays","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 — in vitro and in vivo kinase studies with multiple orthogonal methods","pmids":["8404858"],"is_preprint":false},{"year":1993,"finding":"The CREM KID (kinase-inducible domain) containing Ser133-equivalent acts as a conditional activator that can enhance activity of other activation domains (Q2, GAL4, GCN4) via phosphorylation by PKA, even when attached to a separate polypeptide bound to an adjacent promoter site. CREM alpha and beta contain KID but function as repressors due to absence of activation domains.","method":"Transfection reporter assays with domain swaps and fusion proteins in mammalian cells","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 — functional domain dissection with clear mechanistic readout","pmids":["8102791"],"is_preprint":false},{"year":1993,"finding":"Rhythmic adrenergic signals from the suprachiasmatic nucleus direct circadian ICER expression in the pineal gland via cAMP pathway stimulation, with ICER levels peaking at night and exhibiting a day-night fluctuation.","method":"RNase protection, Northern blot, pharmacological manipulation of adrenergic signaling in vivo","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 — in vivo pharmacological and physiological manipulation with multiple time points","pmids":["8397338"],"is_preprint":false},{"year":1993,"finding":"p34cdc2 kinase phosphorylates CREM tau on multiple serine and threonine residues both in vivo and in vitro; coexpression of constitutively active p34cdc2 strongly reduces CREM tau trans-activation potential without affecting its DNA binding.","method":"In vivo and in vitro phosphorylation assays, EMSA, transfection reporter assays with constitutively active cdc2 mutant","journal":"Molecular endocrinology (Baltimore, Md.)","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro kinase assay plus genetic overexpression functional test","pmids":["8114763"],"is_preprint":false},{"year":1994,"finding":"DNA bending is induced by CREM (and CREB) binding to CRE flanking sequences. Phosphorylation of CREM or CREB enhances the angle of DNA bending. No differences in bending were detected between CREM proteins with the two alternative DNA-binding domains.","method":"Permuted binding site gel retardation assay with bacterially expressed proteins","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 — single lab, direct biochemical measurement of DNA bending","pmids":["8290258"],"is_preprint":false},{"year":1994,"finding":"CREM alpha can form non-functional heterodimers with CREB that prevent gene activation, but when selectively forced into CREB-CREM alpha heterodimers via engineered leucine zippers, CREM alpha contributes to PKA-mediated gene activation in a phosphorylation-dependent manner. Thus the inhibitory function of CREM alpha depends on whether it is in a homodimer or heterodimer context and on phosphorylation state.","method":"Leucine zipper domain engineering to force defined dimer pairs, in vivo transcription assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — elegant domain engineering plus functional transcription assays","pmids":["7961842"],"is_preprint":false},{"year":1994,"finding":"A CREM isoform (CREM delta C-G) expressed in elongated spermatids lacks exons encoding the PKA phosphorylation domain and glutamine-rich activation domains but retains the bZIP DNA-binding domain; it binds CREs, competitively inhibits CREB and CREM CRE binding, and inhibits CRE-driven reporter transcription.","method":"RT-PCR from germ cells, EMSA, transfection reporter assays, immunostaining with CREM antiserum","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — protein characterization with binding and functional assays","pmids":["7809053"],"is_preprint":false},{"year":1995,"finding":"TSH induces ICER (the inducible CREM isoform) in rat thyroid gland and FRTL-5 cells; ICER binds a CRE-like sequence in the TSH receptor (TSH-R) promoter and represses its expression. The kinetics of ICER induction mirrors TSH-R mRNA down-regulation, identifying ICER as a mediator of homologous long-term desensitization of the TSH receptor.","method":"Northern blot, EMSA, transfection reporter assays with ICER overexpression, in vivo TSH administration","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — in vivo and in vitro experiments with binding and functional validation","pmids":["7568187"],"is_preprint":false},{"year":1995,"finding":"A 111-bp first intron of the calspermin gene is required for CREM tau-mediated transcriptional enhancement via CRE motifs; deletion or inversion abolishes CREM tau stimulation; the intron functions as an orientation-dependent, position-independent regulatory element facilitating CREM tau activity.","method":"Deletion/inversion mutagenesis, footprinting, linker scanning, transfection reporter assays with CREM tau","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — systematic mutagenesis with clear mechanistic conclusion","pmids":["7673120"],"is_preprint":false},{"year":1996,"finding":"CREM-deficient mice (generated by homologous recombination) show postmeiotic arrest at the first step of spermiogenesis, complete absence of late spermatids, absence of spermatozoa, increased germ cell apoptosis (~10-fold), and loss of postmeiotic germ cell-specific gene expression. CREM is thus essential for spermiogenesis.","method":"Homologous recombination knockout, histology, TUNEL apoptosis assay, RT-PCR/Northern blot for target gene expression","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 — clean KO with defined cellular and molecular phenotype, replicated by independent lab simultaneously","pmids":["8600390","8600391"],"is_preprint":false},{"year":1996,"finding":"CREM-null mice show dramatic increase in serotonin N-acetyltransferase (NAT) expression in pineal gland. ICER binds a CRE site in the NAT promoter and represses NAT transcription in transfection assays, establishing CREM/ICER as a central regulator of circadian melatonin synthesis.","method":"CREM knockout mice, Northern blot, EMSA, transfection reporter assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — KO phenotype validated by EMSA and reporter assays","pmids":["8943074"],"is_preprint":false},{"year":1996,"finding":"The transcriptional response of the CREM gene to adrenergic stimulation is modulated by prior photoperiod (circadian memory): the balance between positive regulator CREB and negative regulator ICER determines whether the CREM gene is subsensitive or supersensitive to cAMP induction depending on night length.","method":"In vivo photoperiod manipulation, Northern blot analysis, quantification of CREB vs. ICER levels","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 — in vivo physiological epistasis with molecular analysis","pmids":["8609995"],"is_preprint":false},{"year":1998,"finding":"CREM transcription factor coordinates hepatocyte proliferation timing after partial hepatectomy; CREM-/- mice show reduced DNA synthesis, fewer mitotic cells, delayed S-phase entry, and deregulated expression of cyclins A, B, D1, E, cdc2, c-fos, and tyrosine aminotransferase compared to wild-type.","method":"Partial hepatectomy in CREM-/- mice, BrdU incorporation, histone H3 phosphorylation, RT-PCR, immunostaining","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 — KO with specific proliferation phenotype and multiple molecular readouts","pmids":["9851970"],"is_preprint":false},{"year":1999,"finding":"ACT (activator of CREM in testis), a LIM-only protein, was identified via two-hybrid screen as a testis-specific binding partner of CREM. ACT has intrinsic transcriptional activation function and strongly stimulates CREM transcriptional activity in yeast and mammalian cells in a phosphorylation-independent manner, bypassing the classical requirement for Ser117 phosphorylation and CBP interaction.","method":"Yeast two-hybrid screen, co-immunoprecipitation, transfection reporter assays in yeast and mammalian cells","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 — two-hybrid plus reciprocal co-IP plus functional reporter assays, replicated in subsequent studies","pmids":["10086359"],"is_preprint":false},{"year":1999,"finding":"CREB/CREM complex binds the -180 site of the IL-2 promoter in anergic T cells; induction of anergy by prolonged TCR stimulation increases CREB/CREM binding at this site; mutation of the -180 site that specifically reduces CREB/CREM binding decreases susceptibility to anergy-induced IL-2 repression.","method":"EMSA, gel supershift assays, reporter constructs with site-specific mutations, T cell anergy induction","journal":"Journal of immunology (Baltimore, Md. : 1950)","confidence":"High","confidence_rationale":"Tier 2 — binding and functional mutant reporter assays in physiologically relevant T cell anergy system","pmids":["10586058"],"is_preprint":false},{"year":1999,"finding":"CREM-null mice show dramatically increased locomotion, equal locomotor activity throughout the circadian cycle (loss of circadian locomotor variation), and decreased anxiety-like behavior in two behavioral tests, demonstrating CREM's specific role in behavioral and circadian control.","method":"CREM-null mice, open field locomotor tests, anxiety behavioral models (elevated plus maze, light-dark box), circadian activity monitoring","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — clean KO with defined behavioral phenotypes","pmids":["10570204"],"is_preprint":false},{"year":1999,"finding":"CREMtau from germ cell nuclear extracts binds a conserved CYP51-CRE2 element in the CYP51 proximal promoter and activates CYP51 transcription in spermatids; CREM-/- mice lack abundant germ cell-specific CYP51 mRNAs while somatic CYP51 transcripts are unaffected, demonstrating CREM-dependent regulation of a cholesterogenic gene specifically in haploid germ cells.","method":"EMSA with germ cell vs. somatic nuclear extracts, CREM KO mice, Northern blot for CYP51 transcripts, promoter reporter assays","journal":"Molecular endocrinology (Baltimore, Md.)","confidence":"High","confidence_rationale":"Tier 2 — KO mouse phenotype combined with binding and reporter assays","pmids":["10551787"],"is_preprint":false},{"year":2003,"finding":"CREM interacts with the general transcription factor TFIIA (identified by two-hybrid screen from testis cDNA library and confirmed by co-immunoprecipitation); this interaction is restricted to activator isoforms of CREM and does not require Ser117 phosphorylation. CREM does not interact with testis-specific TFIIAtau-ALF. CREM and TFIIA colocalize in spermatocytes and spermatids.","method":"Yeast two-hybrid, co-immunoprecipitation, immunofluorescence co-localization","journal":"Molecular endocrinology (Baltimore, Md.)","confidence":"Medium","confidence_rationale":"Tier 2-3 — two-hybrid confirmed by co-IP and co-localization, single lab","pmids":["14512522"],"is_preprint":false},{"year":2003,"finding":"CREM-null mice display markedly depressed cardiac force-frequency relationship (reduced contractile augmentation and relaxation shortening at faster heart rates) associated with decreased total and serine-phosphorylated phospholamban protein and increased protein phosphatase-1 (PP1) activity, without changes in beta-adrenergic signaling, identifying a novel role for CREM in regulating PP1 activity and cardiac function.","method":"In vivo pressure-volume loops, echocardiography, PP1 activity assay, Western blot, isoproterenol dose-response in CREM-/- mice","journal":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","confidence":"High","confidence_rationale":"Tier 2 — clean KO with specific physiological and biochemical phenotypes","pmids":["12554693"],"is_preprint":false},{"year":2005,"finding":"SRp40, an SR protein splicing factor, regulates the switch in CREM alternative splicing from CREMtau2alpha (activator) to CREMalpha (repressor) in human myometrial cells during pregnancy; SRp40 acts through multiple exonic splicing enhancer (ESE) motifs in alternatively spliced CREM exons.","method":"Transient transfection of splicing factor constructs, in vitro splicing assays, EMSA for SRp40-ESE binding, minigene deletion analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods identifying splicing mechanism","pmids":["16103121"],"is_preprint":false},{"year":2006,"finding":"CREMtau and Tisp40 form a heterodimer that binds CRE (but not UPRE) elements; Tisp40 dramatically enhances the binding of CREMtau to CRE sequences. The Tisp40DeltaTM-CREMtau heterodimer recruits the histone chaperone HIRA to CRE sites. Tisp40alpha mRNA is a direct transcriptional target of CREM, as confirmed by ChIP.","method":"Co-immunoprecipitation, EMSA, ChIP, transfection reporter assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — co-IP, binding assays, ChIP and reporter assays in combination","pmids":["16595651"],"is_preprint":false},{"year":2010,"finding":"SPAG8 (sperm associated antigen 8), a testis-specific protein, associates with ACT (the CREM coactivator) and enhances ACT-mediated CREMtau transcriptional activation by strengthening ACT binding to CREMtau.","method":"Co-immunoprecipitation, pulldown assays, transfection reporter assays","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 3 — co-IP plus reporter assay, single lab","pmids":["20488182"],"is_preprint":false},{"year":2010,"finding":"ChIP-seq mapping in round spermatids shows CREM occupies more than 6700 genomic loci in a highly cell-specific manner, including promoters of spermiogenesis-specific genes and genes expressed in other cell types, indicating remarkably open chromatin in spermatids. Only a small subset of these occupied loci show expression changes in CREM knockout spermatids.","method":"Chromatin immunoprecipitation coupled to sequencing (ChIP-seq) in round spermatids; CREM KO comparison","journal":"BMC genomics","confidence":"High","confidence_rationale":"Tier 2 — genome-wide ChIP-seq in physiologically relevant primary tissue combined with KO comparison","pmids":["20920259"],"is_preprint":false},{"year":2011,"finding":"A novel intronic CREM promoter (P2) upstream of exon 2 harbors functional TATA-box and AP-1 binding sites; T cell activation via CD3/CD28 or PMA/ionomycin enhances P2 promoter activity. In SLE T cells, reduced c-Fos content prevents AP-1-dependent P2 activation; CREM trans-represses c-fos, establishing an autoregulatory feedback between CREM and AP-1.","method":"DNA binding assays (EMSA), chromatin immunoprecipitation, reporter assays, siRNA, T cell stimulation assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods identifying novel promoter and autoregulatory mechanism","pmids":["21757709"],"is_preprint":false},{"year":2013,"finding":"CREMalpha orchestrates epigenetic silencing of the CD8 gene cluster in SLE T cells by recruiting DNA methyltransferase DNMT3a and histone methyltransferase G9a, driving expansion of CD3+CD4-CD8- double-negative T cells.","method":"Co-immunoprecipitation, ChIP, siRNA knockdown, flow cytometry, reporter assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — ChIP and co-IP demonstrate direct epigenetic mechanism with functional consequence","pmids":["24297179"],"is_preprint":false},{"year":2013,"finding":"DAZAP1 regulates alternative splicing of CREM pre-mRNA; DAZAP1 promotes inclusion of CREM exon 4 by binding regulatory sequences in CREM intron 3. Loss of DAZAP1 results in aberrant CREM splicing in mouse testis.","method":"Microarray exon profiling, splicing reporter minigene assays, DAZAP1 mutant binding studies, DAZAP1-null mouse model","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods identifying splicing regulatory mechanism","pmids":["23965306"],"is_preprint":false},{"year":2014,"finding":"CaMK4 is required for Th17 cell differentiation; CaMK4 activates CREMalpha, which in turn promotes IL-17 transcription and activates the AKT/mTOR pathway. Genetic or pharmacological inhibition of CaMK4 decreases CREMalpha activation, reducing IL17A and IL17F mRNA in human SLE T cells.","method":"Genetic CaMK4 knockout, pharmacological inhibition, siRNA in human and mouse T cells, Th17 differentiation assays, cytokine measurements, reporter assays","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 — genetic KO plus pharmacological inhibition plus siRNA in human cells, multiple readouts","pmids":["24667640"],"is_preprint":false},{"year":2016,"finding":"Transgenic cardiac expression of CREM repressor isoform CREM-IbDeltaC-X leads to increased NCX-mediated Ca2+ transport, enhanced NCX1 protein levels, increased INCX, decreased Ito and KChIP2, action potential prolongation, increased early afterdepolarizations, and ventricular extrasystoles, demonstrating CREM repressor's role in arrhythmogenic cardiac remodeling.","method":"Patch clamp, calcium imaging, immunoblotting, RT-PCR, transgenic mouse model","journal":"Basic research in cardiology","confidence":"High","confidence_rationale":"Tier 2 — transgenic model with multiple electrophysiological and molecular readouts","pmids":["26818679"],"is_preprint":false},{"year":2025,"finding":"CREM is induced in CAR-NK cells by both CAR activation and IL-15 signaling via the PKA-CREB signaling pathway (downstream of ITAM signaling). CREM deletion enhances CAR-NK cell effector function in vitro and in vivo and increases resistance to tumor-induced immunosuppression. CREM exerts its regulatory functions through epigenetic reprogramming of CAR-NK cells.","method":"Transcriptomic analysis, CREM deletion via genetic editing, in vitro cytotoxicity assays, in vivo tumor models, epigenetic profiling","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 — genetic deletion with in vitro and in vivo functional readouts plus mechanistic pathway elucidation","pmids":["40468083"],"is_preprint":false},{"year":2003,"finding":"ICER (inducible CREM isoform) binds a CRE-like sequence in the CYP19 (aromatase) ovarian promoter; ICER overexpression suppresses FSH-induced CYP19 promoter activity in granulosa cells and R2C cells; stable antisense ICER blocks 24-48h cAMP-induced downregulation, identifying ICER/CREM as a mediator of LH-induced aromatase downregulation during luteinization.","method":"EMSA with supershift, transfection reporter assays, stable ICER overexpression and antisense cell lines","journal":"The Journal of endocrinology","confidence":"High","confidence_rationale":"Tier 2 — binding assays plus gain/loss of function reporter experiments","pmids":["14656211"],"is_preprint":false}],"current_model":"CREM is a modular bZIP transcription factor that generates multiple isoforms—repressors and activators—by cell-specific alternative splicing and alternative promoter usage; repressor isoforms (CREM alpha/beta/gamma, ICER) compete with CREB at CRE and TRE sites to antagonize cAMP-induced transcription, while the activator isoform CREMtau is phosphorylated at Ser117 by PKA (and other kinases) to recruit CBP, or alternatively bypasses phosphorylation by associating with the testis-specific LIM-only coactivator ACT (which also recruits TFIIA and HIRA), enabling phosphorylation-independent transcriptional activation of postmeiotic germ cell genes essential for spermiogenesis; ICER is itself transcribed from an intronic cAMP-inducible promoter and autorepresses its own expression to generate negative feedback loops governing circadian rhythms, hormonal desensitization, and transient cAMP responses in diverse tissues including pineal gland, thyroid, liver, heart, and immune cells."},"narrative":{"teleology":[{"year":1991,"claim":"The discovery that a single gene generates multiple CRE-binding repressor isoforms via alternative splicing established CREM as an antagonist of cAMP-induced transcription, revealing that the cAMP pathway has a dedicated transcriptional brake distinct from CREB.","evidence":"PCR, RNase protection, DNA binding assays, and reporter assays characterizing CREM isoforms and their repressor activity on CRE-driven promoters","pmids":["1847666","1647033"],"confidence":"High","gaps":["Activator isoforms not yet identified","In vivo relevance of repression not demonstrated","Structural basis of repressor vs. activator function unknown"]},{"year":1992,"claim":"Identification of CREMτ as an activator isoform and demonstration that a developmental splicing switch converts CREM from repressor to activator during spermatogenesis revealed how a single locus can toggle between opposing transcriptional outputs in a tissue-specific manner.","evidence":"RT-PCR, Northern blot, and reporter assays showing stage-specific CREMτ accumulation in postmeiotic germ cells; separate demonstration that CREM repressors bind TRE sites to inhibit Jun-mediated transcription","pmids":["1370576","1429597"],"confidence":"High","gaps":["Upstream signal driving the splicing switch unknown","Target genes of CREMτ in spermatids not identified","Mechanism by which CREMτ activates transcription not resolved"]},{"year":1993,"claim":"Multiple advances in 1993 defined the core activation mechanism: CREMτ is phosphorylated at Ser117 by PKA and other kinases to create a conditional activation domain (KID), ICER was identified as a cAMP-inducible autorepressive isoform from an intronic promoter, and circadian ICER oscillation was linked to adrenergic signaling in the pineal gland—together establishing the molecular logic of CREM's dual activator/autorepressor feedback circuit.","evidence":"In vitro kinase assays, in vivo phosphorylation labeling, domain-swap reporter assays, ICER promoter analysis, Northern blot time courses in pineal gland, pharmacological manipulation of adrenergic signaling","pmids":["8114765","8404858","8102791","8252624","8397338","8114763"],"confidence":"High","gaps":["Coactivator recruited by phospho-KID not identified","Whether ICER feedback is sufficient for circadian rhythms not tested genetically","Contribution of casein kinases vs. PKA vs. cdc2 to CREM function in vivo unclear"]},{"year":1993,"claim":"FSH was identified as the pituitary hormone responsible for the CREMτ splicing switch in spermatogenesis, acting through alternative polyadenylation to stabilize CREMτ transcripts—connecting an endocrine axis to a post-transcriptional gene regulation event.","evidence":"Hypophysectomy abolishes CREMτ in testis; direct FSH administration restores it; seasonal spermatogenesis in hamsters as a natural model","pmids":["7681549"],"confidence":"High","gaps":["Splicing factors mediating the FSH-driven switch not identified","Whether polyadenylation change is direct or indirect unknown"]},{"year":1994,"claim":"Structure–function studies showed that CREM's repressor versus activator output depends on modular domain composition and dimerization context: a minimal bZIP repressor lacking activation domains antagonizes CRE-driven transcription, while forced CREB–CREMα heterodimers can activate in a phosphorylation-dependent manner, demonstrating that dimer identity dictates functional outcome.","evidence":"Engineered leucine zipper domains to force defined dimer pairs, reporter assays, phosphorylation mutants; identification of spermatid-specific CREMδC-G repressor isoform","pmids":["7961842","7809053","8290258"],"confidence":"High","gaps":["Crystal structure of CREM dimers not determined","Relative abundance of different dimers in vivo unknown"]},{"year":1996,"claim":"CREM knockout mice revealed that CREM is essential for spermiogenesis (complete postmeiotic arrest, loss of spermatozoa) and for circadian regulation of melatonin synthesis (derepression of NAT), establishing non-redundant in vivo functions for both the activator and ICER repressor arms.","evidence":"Homologous recombination knockout in two independent labs; histology, TUNEL, RT-PCR for target genes; ICER–CRE binding and NAT derepression in KO pineal","pmids":["8600390","8600391","8943074"],"confidence":"High","gaps":["Which of the >6000 CREM-occupied loci are functionally required for spermiogenesis unknown","Redundancy with CREB in non-testis tissues not systematically tested"]},{"year":1996,"claim":"Demonstration that the balance between CREB and ICER at the CREM intronic promoter encodes photoperiod history ('circadian memory') revealed how the same autoregulatory loop can produce different transcriptional responses depending on prior light exposure.","evidence":"In vivo photoperiod manipulation with quantification of CREB vs. ICER protein levels and CREM transcriptional responsiveness","pmids":["8609995"],"confidence":"High","gaps":["Chromatin state changes at the ICER promoter across photoperiods not examined","Whether this memory mechanism operates outside the pineal gland unknown"]},{"year":1998,"claim":"CREM was shown to coordinate hepatocyte proliferation timing after partial hepatectomy, with CREM-null mice exhibiting delayed S-phase entry and deregulated cyclin/cdc2 expression, extending CREM's functional repertoire beyond endocrine tissues to regenerative cell cycle control.","evidence":"Partial hepatectomy in CREM-/- mice with BrdU incorporation, histone H3 phosphorylation, RT-PCR for cell cycle genes","pmids":["9851970"],"confidence":"High","gaps":["Direct vs. indirect regulation of cyclin genes by CREM not distinguished","Whether ICER or CREMτ mediates the hepatic phenotype unclear"]},{"year":1999,"claim":"Discovery of ACT, a testis-specific LIM-only coactivator that stimulates CREMτ transcription without requiring Ser117 phosphorylation or CBP, revealed a phosphorylation-independent activation pathway explaining how CREMτ can activate postmeiotic genes even in the absence of active PKA signaling.","evidence":"Yeast two-hybrid screen, co-immunoprecipitation, reporter assays in yeast and mammalian cells showing phosphorylation-independent activation","pmids":["10086359"],"confidence":"High","gaps":["Structural basis of ACT–CREMτ interaction unknown","Whether ACT is the predominant coactivator in vivo or works alongside CBP unclear"]},{"year":1999,"claim":"CREB/CREM binding at the IL-2 promoter CRE was shown to mediate T cell anergy, establishing CREM as a regulator of adaptive immune tolerance and linking it to autoimmune pathology.","evidence":"EMSA supershift, site-directed mutagenesis of the -180 CRE in IL-2 reporter, anergy induction in T cells","pmids":["10586058"],"confidence":"High","gaps":["Which CREM isoform predominates in anergic T cells not determined","In vivo contribution of CREM to anergy vs. other CRE-binding factors not resolved"]},{"year":2003,"claim":"Identification of TFIIA as a direct CREMτ-interacting partner in testis, and ICER-mediated repression of aromatase (CYP19) and TSH receptor, expanded the known cofactor repertoire and target gene landscape of CREM across reproductive and endocrine tissues.","evidence":"Two-hybrid screen, co-IP, co-localization in spermatocytes/spermatids for TFIIA; EMSA and reporter assays for ICER on CYP19 and TSH-R promoters","pmids":["14512522","14656211","7568187"],"confidence":"Medium","gaps":["Functional consequence of TFIIA interaction for specific target gene expression not shown in vivo","Whether TFIIA and ACT cooperate or compete for CREMτ binding unclear"]},{"year":2005,"claim":"Identification of SRp40 as a splicing factor that regulates the CREM activator-to-repressor switch via exonic splicing enhancers provided the first molecular mechanism for tissue-specific CREM isoform choice outside the germline.","evidence":"Splicing factor overexpression, in vitro splicing, EMSA for SRp40-ESE binding, minigene analysis in human myometrial cells","pmids":["16103121"],"confidence":"High","gaps":["Whether SRp40 also operates in testis or other tissues not tested","Upstream signals regulating SRp40 activity on CREM exons unknown"]},{"year":2006,"claim":"Demonstration that CREMτ heterodimerizes with Tisp40 to enhance CRE binding and recruit the histone chaperone HIRA added an epigenetic dimension to CREMτ's activation mechanism in spermatids.","evidence":"Co-IP, EMSA showing enhanced binding, ChIP confirming Tisp40 is a direct CREM target","pmids":["16595651"],"confidence":"High","gaps":["Whether HIRA recruitment leads to specific histone variant deposition at CREMτ target genes not shown","Functional redundancy between ACT and Tisp40 pathways untested"]},{"year":2010,"claim":"Genome-wide ChIP-seq in round spermatids revealed that CREM occupies over 6700 loci—far exceeding the number of expression-dependent targets—indicating that CREM binding in spermatids occurs across broadly open chromatin and that occupancy alone is insufficient for transcriptional regulation.","evidence":"ChIP-seq in purified round spermatids with comparison to CREM-KO expression changes","pmids":["20920259"],"confidence":"High","gaps":["What distinguishes functionally productive CREM binding from passive occupancy remains unknown","Cofactor co-occupancy at regulated vs. non-regulated sites not mapped"]},{"year":2013,"claim":"CREMα was shown to recruit DNMT3a and G9a to epigenetically silence the CD8 locus in SLE T cells, mechanistically explaining the expansion of pathogenic double-negative T cells and establishing CREM as an epigenetic effector in autoimmunity; separately, DAZAP1 was identified as a splicing regulator of CREM exon inclusion in testis.","evidence":"ChIP, co-IP, siRNA, flow cytometry in SLE T cells for epigenetic silencing; DAZAP1-null mouse and minigene assays for splicing","pmids":["24297179","23965306"],"confidence":"High","gaps":["Whether CREMα recruits DNMT3a/G9a at other immune loci not tested genome-wide","Contribution of DAZAP1 vs. SRp40 to CREM splicing in different tissues not compared"]},{"year":2014,"claim":"CaMK4 was identified as an upstream kinase that activates CREMα to drive IL-17 transcription and Th17 differentiation, positioning CREM within the CaMK4–AKT/mTOR signaling axis relevant to SLE pathogenesis.","evidence":"CaMK4 knockout, pharmacological inhibition, siRNA in human SLE T cells, Th17 differentiation assays","pmids":["24667640"],"confidence":"High","gaps":["Specific CREMα phosphorylation site(s) targeted by CaMK4 not mapped","Whether CaMK4–CREM axis operates in other Th subsets not examined"]},{"year":2016,"claim":"Transgenic cardiac expression of a CREM repressor isoform caused arrhythmogenic remodeling with action potential prolongation, early afterdepolarizations, and altered calcium handling, demonstrating that CREM repressor activity directly shapes cardiac electrophysiology.","evidence":"Transgenic mouse, patch clamp, calcium imaging, immunoblotting for NCX1, KChIP2, phospholamban","pmids":["26818679"],"confidence":"High","gaps":["Which CREM target genes mediate the ion channel remodeling not identified by ChIP","Whether endogenous CREM repressor isoforms reach pathological levels in human heart disease unknown"]},{"year":2025,"claim":"CREM was identified as a negative regulator of CAR-NK cell cytotoxicity: CREM is induced downstream of CAR/ITAM and IL-15/PKA-CREB signaling, and its deletion enhances effector function and resistance to tumor-induced immunosuppression through epigenetic reprogramming, opening a new immunotherapy-relevant axis.","evidence":"CREM deletion by genetic editing in CAR-NK cells, in vitro cytotoxicity, in vivo tumor models, transcriptomic and epigenetic profiling","pmids":["40468083"],"confidence":"High","gaps":["Specific epigenetic targets reprogrammed by CREM deletion in NK cells not fully characterized","Whether CREM also limits CAR-T cell function through similar mechanisms not tested"]},{"year":null,"claim":"Key unresolved questions include: what distinguishes functionally productive CREM occupancy from passive binding at the thousands of open-chromatin sites in spermatids; how the multiple coactivators (ACT, TFIIA, HIRA, CBP) are coordinated at specific target promoters; and whether the CREM-mediated epigenetic silencing mechanism discovered in SLE T cells operates genome-wide across immune cell subsets.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural model of CREMτ with any coactivator","Genome-wide cofactor co-occupancy map at CREM-bound sites lacking","Therapeutic targeting of specific CREM isoforms not achieved"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[0,2,3,6,7,14,22,28,30]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,1,4,6,9,17,32,34,36]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,6,25,30,32]}],"pathway":[],"complexes":[],"partners":["CREB1","ACT","TFIIA","DNMT3A","G9A","HIRA","TISP40","CBP"],"other_free_text":[]},"mechanistic_narrative":"CREM is a modular bZIP transcription factor that generates functionally antagonistic isoforms—repressors and activators—through cell-specific alternative splicing, alternative promoter usage, and regulated polyadenylation, enabling it to serve as a master switch governing cAMP-responsive gene expression in spermatogenesis, circadian rhythmicity, immune cell function, and cardiac physiology [PMID:1847666, PMID:1370576, PMID:8252624, PMID:8397338, PMID:8600390]. Repressor isoforms (CREMα/β/γ and the cAMP-inducible ICER) compete with CREB at CRE and TRE sites to antagonize transcription and create negative autoregulatory feedback loops that mediate hormonal desensitization and circadian oscillations, while in T cells CREMα recruits DNMT3a and G9a to epigenetically silence target loci such as the CD8 cluster [PMID:8252624, PMID:1429597, PMID:24297179]. The activator isoform CREMτ, induced in postmeiotic germ cells by FSH-driven alternative splicing, is phosphorylated at Ser117 by PKA and other kinases to recruit CBP, but can also bypass phosphorylation-dependent activation through association with the testis-specific LIM-only coactivator ACT and the general transcription factor TFIIA, driving expression of spermiogenesis genes whose loss in CREM-null mice causes complete postmeiotic arrest and male infertility [PMID:8114765, PMID:10086359, PMID:14512522, PMID:8600390]. CREM deletion also enhances CAR-NK cell effector function through epigenetic reprogramming, identifying CREM as a negative regulator of immune cytotoxicity [PMID:40468083]."},"prefetch_data":{"uniprot":{"accession":"Q03060","full_name":"cAMP-responsive element modulator","aliases":["Inducible cAMP early repressor","ICER"],"length_aa":345,"mass_kda":37.0,"function":"Transcriptional regulator that binds the cAMP response element (CRE), a sequence present in many viral and cellular promoters. Isoforms are either transcriptional activators or repressors. Plays a role in spermatogenesis and is involved in spermatid maturation (PubMed:10373550) May play a role in the regulation of the circadian clock: acts as a transcriptional repressor of the core circadian component PER1 by directly binding to cAMP response elements in its promoter","subcellular_location":"Cytoplasm; Nucleus","url":"https://www.uniprot.org/uniprotkb/Q03060/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CREM","classification":"Not Classified","n_dependent_lines":2,"n_total_lines":1208,"dependency_fraction":0.0016556291390728477},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/CREM","total_profiled":1310},"omim":[{"mim_id":"614994","title":"CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE IG; CAMK1G","url":"https://www.omim.org/entry/614994"},{"mim_id":"612786","title":"CYCLIN Y; CCNY","url":"https://www.omim.org/entry/612786"},{"mim_id":"605571","title":"PIWI-LIKE RNA-MEDIATED GENE SILENCING 1; PIWIL1","url":"https://www.omim.org/entry/605571"},{"mim_id":"605521","title":"TATA BOX-BINDING PROTEIN-LIKE PROTEIN 1; TBPL1","url":"https://www.omim.org/entry/605521"},{"mim_id":"605126","title":"FOUR-AND-A-HALF LIM DOMAINS 5; FHL5","url":"https://www.omim.org/entry/605126"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Vesicles","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"testis","ntpm":194.3}],"url":"https://www.proteinatlas.org/search/CREM"},"hgnc":{"alias_symbol":["hCREM-2"],"prev_symbol":[]},"alphafold":{"accession":"Q03060","domains":[{"cath_id":"1.20.5","chopping":"304-339","consensus_level":"medium","plddt":97.3142,"start":304,"end":339}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q03060","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q03060-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q03060-F1-predicted_aligned_error_v6.png","plddt_mean":60.09},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CREM","jax_strain_url":"https://www.jax.org/strain/search?query=CREM"},"sequence":{"accession":"Q03060","fasta_url":"https://rest.uniprot.org/uniprotkb/Q03060.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q03060/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q03060"}},"corpus_meta":[{"pmid":"1847666","id":"PMC_1847666","title":"CREM gene: use of alternative DNA-binding domains generates multiple antagonists of cAMP-induced transcription.","date":"1991","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/1847666","citation_count":619,"is_preprint":false},{"pmid":"8252624","id":"PMC_8252624","title":"Inducibility and negative autoregulation of CREM: an alternative promoter directs the expression of ICER, an early response repressor.","date":"1993","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/8252624","citation_count":518,"is_preprint":false},{"pmid":"8600390","id":"PMC_8600390","title":"Spermiogenesis deficiency and germ-cell apoptosis in CREM-mutant mice.","date":"1996","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/8600390","citation_count":485,"is_preprint":false},{"pmid":"8600391","id":"PMC_8600391","title":"Severe impairment of spermatogenesis in mice lacking the CREM gene.","date":"1996","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/8600391","citation_count":454,"is_preprint":false},{"pmid":"1370576","id":"PMC_1370576","title":"Developmental switch of CREM function during spermatogenesis: from antagonist to activator.","date":"1992","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/1370576","citation_count":444,"is_preprint":false},{"pmid":"8397338","id":"PMC_8397338","title":"Adrenergic signals direct rhythmic expression of transcriptional repressor CREM in the pineal gland.","date":"1993","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/8397338","citation_count":362,"is_preprint":false},{"pmid":"10390618","id":"PMC_10390618","title":"Signaling routes to CREM and CREB: plasticity in transcriptional activation.","date":"1999","source":"Trends in biochemical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/10390618","citation_count":241,"is_preprint":false},{"pmid":"7681549","id":"PMC_7681549","title":"Pituitary hormone FSH directs the CREM functional switch during spermatogenesis.","date":"1993","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/7681549","citation_count":236,"is_preprint":false},{"pmid":"8114765","id":"PMC_8114765","title":"Induction of CREM activator proteins in spermatids: down-stream targets and implications for haploid germ cell differentiation.","date":"1993","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/8114765","citation_count":206,"is_preprint":false},{"pmid":"8458330","id":"PMC_8458330","title":"The functional versatility of CREM is determined by its modular structure.","date":"1993","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/8458330","citation_count":202,"is_preprint":false},{"pmid":"10086359","id":"PMC_10086359","title":"CBP-independent activation of CREM and CREB by the LIM-only protein ACT.","date":"1999","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/10086359","citation_count":190,"is_preprint":false},{"pmid":"1429597","id":"PMC_1429597","title":"Transcriptional cross-talk: nuclear factors CREM and CREB bind to AP-1 sites and inhibit activation by Jun.","date":"1992","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/1429597","citation_count":188,"is_preprint":false},{"pmid":"24667640","id":"PMC_24667640","title":"CaMK4-dependent activation of AKT/mTOR and CREM-α underlies autoimmunity-associated Th17 imbalance.","date":"2014","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/24667640","citation_count":183,"is_preprint":false},{"pmid":"8404858","id":"PMC_8404858","title":"Multiple and cooperative phosphorylation events regulate the CREM activator function.","date":"1993","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/8404858","citation_count":180,"is_preprint":false},{"pmid":"8102791","id":"PMC_8102791","title":"Protein-kinase-A-dependent activator in transcription factor CREB reveals new role for CREM repressors.","date":"1993","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/8102791","citation_count":153,"is_preprint":false},{"pmid":"11988318","id":"PMC_11988318","title":"The expanding family of CREB/CREM transcription factors that are involved with spermatogenesis.","date":"2002","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/11988318","citation_count":150,"is_preprint":false},{"pmid":"11969286","id":"PMC_11969286","title":"Coupling cAMP signaling to transcription in the liver: pivotal role of CREB and CREM.","date":"2002","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/11969286","citation_count":146,"is_preprint":false},{"pmid":"8943074","id":"PMC_8943074","title":"Transcriptional control of circadian hormone synthesis via the CREM feedback loop.","date":"1996","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/8943074","citation_count":130,"is_preprint":false},{"pmid":"1647033","id":"PMC_1647033","title":"Transcriptional antagonist cAMP-responsive element modulator (CREM) down-regulates c-fos cAMP-induced expression.","date":"1991","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/1647033","citation_count":109,"is_preprint":false},{"pmid":"9247115","id":"PMC_9247115","title":"Cyclic AMP signalling and cellular proliferation: regulation of CREB and CREM.","date":"1997","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/9247115","citation_count":98,"is_preprint":false},{"pmid":"29975250","id":"PMC_29975250","title":"Molecular Profiling of Hyalinizing Clear Cell Carcinomas Revealed a Subset of Tumors Harboring a Novel EWSR1-CREM Fusion: Report of 3 Cases.","date":"2018","source":"The American journal of surgical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/29975250","citation_count":91,"is_preprint":false},{"pmid":"9510006","id":"PMC_9510006","title":"Testicular cAMP responsive element modulator (CREM) protein is expressed in round spermatids but is absent or reduced in men with round spermatid maturation arrest.","date":"1998","source":"Molecular human reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/9510006","citation_count":88,"is_preprint":false},{"pmid":"10586058","id":"PMC_10586058","title":"The -180 site of the IL-2 promoter is the target of CREB/CREM binding in T cell anergy.","date":"1999","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/10586058","citation_count":88,"is_preprint":false},{"pmid":"8386526","id":"PMC_8386526","title":"Transcriptional response to cAMP in brain: specific distribution and induction of CREM antagonists.","date":"1993","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/8386526","citation_count":87,"is_preprint":false},{"pmid":"7568187","id":"PMC_7568187","title":"Thyroid-stimulating hormone (TSH)-directed induction of the CREM gene in the thyroid gland participates in the long-term desensitization of the TSH receptor.","date":"1995","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/7568187","citation_count":85,"is_preprint":false},{"pmid":"8609995","id":"PMC_8609995","title":"Adaptive inducibility of CREM as transcriptional memory of circadian rhythms.","date":"1996","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/8609995","citation_count":82,"is_preprint":false},{"pmid":"7809053","id":"PMC_7809053","title":"An isoform of transcription factor CREM expressed during spermatogenesis lacks the phosphorylation domain and represses cAMP-induced transcription.","date":"1994","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/7809053","citation_count":75,"is_preprint":false},{"pmid":"31305268","id":"PMC_31305268","title":"Expanding the Phenotypic Spectrum of Mesenchymal Tumors Harboring the EWSR1-CREM Fusion.","date":"2019","source":"The American journal of surgical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/31305268","citation_count":74,"is_preprint":false},{"pmid":"10551787","id":"PMC_10551787","title":"Cyclic adenosine 3',5'-monophosphate(cAMP)/cAMP-responsive element modulator (CREM)-dependent regulation of cholesterogenic lanosterol 14alpha-demethylase (CYP51) in spermatids.","date":"1999","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/10551787","citation_count":69,"is_preprint":false},{"pmid":"18406739","id":"PMC_18406739","title":"Role of transcription factors CREB and CREM in cAMP-regulated transcription during spermatogenesis.","date":"1996","source":"Trends in endocrinology and metabolism: TEM","url":"https://pubmed.ncbi.nlm.nih.gov/18406739","citation_count":68,"is_preprint":false},{"pmid":"9813195","id":"PMC_9813195","title":"CREM: a master-switch governing male germ cells differentiation and apoptosis.","date":"1998","source":"Seminars in cell & developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/9813195","citation_count":65,"is_preprint":false},{"pmid":"24297179","id":"PMC_24297179","title":"cAMP responsive element modulator (CREM) α mediates chromatin remodeling of CD8 during the generation of CD3+ CD4- CD8- T cells.","date":"2013","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24297179","citation_count":65,"is_preprint":false},{"pmid":"8994192","id":"PMC_8994192","title":"Human endometrial stromal cells express novel isoforms of the transcriptional modulator CREM and up-regulate ICER in the course of decidualization.","date":"1997","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/8994192","citation_count":64,"is_preprint":false},{"pmid":"8592516","id":"PMC_8592516","title":"Developmental maturation of pineal gland function: synchronized CREM inducibility and adrenergic stimulation.","date":"1995","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/8592516","citation_count":61,"is_preprint":false},{"pmid":"21507395","id":"PMC_21507395","title":"Abnormal methylation of the promoter of CREM is broadly associated with male factor infertility and poor sperm quality but is improved in sperm selected by density gradient centrifugation.","date":"2011","source":"Fertility and sterility","url":"https://pubmed.ncbi.nlm.nih.gov/21507395","citation_count":61,"is_preprint":false},{"pmid":"10570204","id":"PMC_10570204","title":"Altered emotional and locomotor responses in mice deficient in the transcription factor CREM.","date":"1999","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/10570204","citation_count":60,"is_preprint":false},{"pmid":"9851970","id":"PMC_9851970","title":"Transcription factor CREM coordinates the timing of hepatocyte proliferation in the regenerating liver.","date":"1998","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/9851970","citation_count":58,"is_preprint":false},{"pmid":"17372992","id":"PMC_17372992","title":"ICER/CREM-mediated transcriptional attenuation of IL-2 and its role in suppression by regulatory T cells.","date":"2007","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/17372992","citation_count":55,"is_preprint":false},{"pmid":"20920259","id":"PMC_20920259","title":"Cell-specific occupancy of an extended repertoire of CREM and CREB binding loci in male germ cells.","date":"2010","source":"BMC genomics","url":"https://pubmed.ncbi.nlm.nih.gov/20920259","citation_count":54,"is_preprint":false},{"pmid":"11380701","id":"PMC_11380701","title":"cAMP response element modulator (CREM): an essential factor for spermatogenesis in primates?","date":"2001","source":"International journal of andrology","url":"https://pubmed.ncbi.nlm.nih.gov/11380701","citation_count":53,"is_preprint":false},{"pmid":"9129151","id":"PMC_9129151","title":"Cyclic AMP signalling pathway and cellular proliferation: induction of CREM during liver regeneration.","date":"1997","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/9129151","citation_count":52,"is_preprint":false},{"pmid":"7916662","id":"PMC_7916662","title":"Human CREM gene: evolutionary conservation, chromosomal localization, and inducibility of the transcript.","date":"1993","source":"Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/7916662","citation_count":46,"is_preprint":false},{"pmid":"16893891","id":"PMC_16893891","title":"Transcriptional regulation of the glucose-6-phosphatase gene by cAMP/vasoactive intestinal peptide in the intestine. Role of HNF4alpha, CREM, HNF1alpha, and C/EBPalpha.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16893891","citation_count":45,"is_preprint":false},{"pmid":"11079454","id":"PMC_11079454","title":"CREM, a master-switch of the transcriptional cascade in male germ cells.","date":"2000","source":"Journal of endocrinological investigation","url":"https://pubmed.ncbi.nlm.nih.gov/11079454","citation_count":43,"is_preprint":false},{"pmid":"16981198","id":"PMC_16981198","title":"Survival of DA neurons is independent of CREM upregulation in absence of CREB.","date":"2006","source":"Genesis (New York, N.Y. : 2000)","url":"https://pubmed.ncbi.nlm.nih.gov/16981198","citation_count":42,"is_preprint":false},{"pmid":"11420126","id":"PMC_11420126","title":"Transcriptional cascades during spermatogenesis: pivotal role of CREM and ACT.","date":"2001","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/11420126","citation_count":39,"is_preprint":false},{"pmid":"22384077","id":"PMC_22384077","title":"Novel insights into the downstream pathways and targets controlled by transcription factors CREM in the testis.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22384077","citation_count":39,"is_preprint":false},{"pmid":"24007532","id":"PMC_24007532","title":"Regulatory T-cells and cAMP suppress effector T-cells independently of PKA-CREM/ICER: a potential role for Epac.","date":"2013","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/24007532","citation_count":38,"is_preprint":false},{"pmid":"14754893","id":"PMC_14754893","title":"PE-1/METS, an antiproliferative Ets repressor factor, is induced by CREB-1/CREM-1 during macrophage differentiation.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14754893","citation_count":38,"is_preprint":false},{"pmid":"15705296","id":"PMC_15705296","title":"Genetic control of spermiogenesis: insights from the CREM gene and implications for human infertility.","date":"2005","source":"Reproductive biomedicine online","url":"https://pubmed.ncbi.nlm.nih.gov/15705296","citation_count":37,"is_preprint":false},{"pmid":"8522985","id":"PMC_8522985","title":"Electroconvulsive seizure increases the expression of CREM (cyclic AMP response element modulator) and ICER (inducible cyclic AMP early repressor) in rat brain.","date":"1996","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8522985","citation_count":36,"is_preprint":false},{"pmid":"8735279","id":"PMC_8735279","title":"CREM: a master-switch in the transcriptional response to cAMP.","date":"1996","source":"Philosophical transactions of the Royal Society of London. Series B, Biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/8735279","citation_count":35,"is_preprint":false},{"pmid":"10824972","id":"PMC_10824972","title":"CREM: a master-switch regulating the balance between differentiation and apoptosis in male germ cells.","date":"2000","source":"Molecular reproduction and development","url":"https://pubmed.ncbi.nlm.nih.gov/10824972","citation_count":34,"is_preprint":false},{"pmid":"7961842","id":"PMC_7961842","title":"Modulatory function of CREB.CREM alpha heterodimers depends upon CREM alpha phosphorylation.","date":"1994","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7961842","citation_count":32,"is_preprint":false},{"pmid":"11044457","id":"PMC_11044457","title":"CREM activator and repressor isoforms in human testis: sequence variations and inaccurate splicing during impaired spermatogenesis.","date":"2000","source":"Molecular human reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/11044457","citation_count":32,"is_preprint":false},{"pmid":"18775413","id":"PMC_18775413","title":"CREM modulates the circadian expression of CYP51, HMGCR and cholesterogenesis in the liver.","date":"2008","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/18775413","citation_count":29,"is_preprint":false},{"pmid":"14512522","id":"PMC_14512522","title":"Transcriptional control in male germ cells: general factor TFIIA participates in CREM-dependent gene activation.","date":"2003","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/14512522","citation_count":29,"is_preprint":false},{"pmid":"40468083","id":"PMC_40468083","title":"CREM is a regulatory checkpoint of CAR and IL-15 signalling in NK cells.","date":"2025","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/40468083","citation_count":28,"is_preprint":false},{"pmid":"19144833","id":"PMC_19144833","title":"The CREB/CREM transcription factors negatively regulate early synaptogenesis and spontaneous network activity.","date":"2009","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/19144833","citation_count":28,"is_preprint":false},{"pmid":"20488182","id":"PMC_20488182","title":"Sperm associated antigen 8 (SPAG8), a novel regulator of activator of CREM in testis during spermatogenesis.","date":"2010","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/20488182","citation_count":28,"is_preprint":false},{"pmid":"21757709","id":"PMC_21757709","title":"A novel intronic cAMP response element modulator (CREM) promoter is regulated by activator protein-1 (AP-1) and accounts for altered activation-induced CREM expression in T cells from patients with systemic lupus erythematosus.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21757709","citation_count":28,"is_preprint":false},{"pmid":"8290258","id":"PMC_8290258","title":"DNA bending by transcription factors CREM and CREB.","date":"1994","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/8290258","citation_count":27,"is_preprint":false},{"pmid":"14742698","id":"PMC_14742698","title":"Expression of activator of CREM in the testis (ACT) during normal and impaired spermatogenesis: correlation with CREM expression.","date":"2004","source":"Molecular human reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/14742698","citation_count":27,"is_preprint":false},{"pmid":"8114763","id":"PMC_8114763","title":"Phosphorylation and negative regulation of the transcriptional activator CREM by p34cdc2.","date":"1993","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/8114763","citation_count":26,"is_preprint":false},{"pmid":"8650267","id":"PMC_8650267","title":"The nuclear response to cAMP: role of transcription factor CREM.","date":"1996","source":"Philosophical transactions of the Royal Society of London. Series B, Biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/8650267","citation_count":25,"is_preprint":false},{"pmid":"11079452","id":"PMC_11079452","title":"The CREM system in human spermatogenesis.","date":"2000","source":"Journal of endocrinological investigation","url":"https://pubmed.ncbi.nlm.nih.gov/11079452","citation_count":25,"is_preprint":false},{"pmid":"18295410","id":"PMC_18295410","title":"The role of transcription factors cyclic-AMP responsive element modulator (CREM) and inducible cyclic-AMP early repressor (ICER) in epileptogenesis.","date":"2008","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/18295410","citation_count":25,"is_preprint":false},{"pmid":"34228212","id":"PMC_34228212","title":"Intra-abdominal EWSR1/FUS-CREM-rearranged malignant epithelioid neoplasms: two cases of an emerging aggressive entity with emphasis on misleading immunophenotype.","date":"2021","source":"Virchows Archiv : an international journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/34228212","citation_count":24,"is_preprint":false},{"pmid":"16595651","id":"PMC_16595651","title":"Transcription factors, cAMP-responsive element modulator (CREM) and Tisp40, act in concert in postmeiotic transcriptional regulation.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16595651","citation_count":24,"is_preprint":false},{"pmid":"29925386","id":"PMC_29925386","title":"The transcription factor CREM drives an inflammatory phenotype of T cells in oligoarticular juvenile idiopathic arthritis.","date":"2018","source":"Pediatric rheumatology online journal","url":"https://pubmed.ncbi.nlm.nih.gov/29925386","citation_count":24,"is_preprint":false},{"pmid":"26818679","id":"PMC_26818679","title":"Cardiac expression of the CREM repressor isoform CREM-IbΔC-X in mice leads to arrhythmogenic alterations in ventricular cardiomyocytes.","date":"2016","source":"Basic research in cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/26818679","citation_count":23,"is_preprint":false},{"pmid":"22569987","id":"PMC_22569987","title":"Cyclic AMP response element modulator-1 (CREM-1) involves in neuronal apoptosis after traumatic brain injury.","date":"2012","source":"Journal of molecular neuroscience : MN","url":"https://pubmed.ncbi.nlm.nih.gov/22569987","citation_count":23,"is_preprint":false},{"pmid":"12864917","id":"PMC_12864917","title":"The AmCREB gene is an ortholog of the mammalian CREB/CREM family of transcription factors and encodes several splice variants in the honeybee brain.","date":"2003","source":"Insect molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/12864917","citation_count":23,"is_preprint":false},{"pmid":"34261344","id":"PMC_34261344","title":"Expression of Transcription Factor CREM in Human Tissues.","date":"2021","source":"The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society","url":"https://pubmed.ncbi.nlm.nih.gov/34261344","citation_count":22,"is_preprint":false},{"pmid":"15595950","id":"PMC_15595950","title":"Specialized rules of gene transcription in male germ cells: the CREM paradigm.","date":"2004","source":"International journal of andrology","url":"https://pubmed.ncbi.nlm.nih.gov/15595950","citation_count":22,"is_preprint":false},{"pmid":"34648001","id":"PMC_34648001","title":"Genetic inhibition of nuclear factor of activated T-cell c2 prevents atrial fibrillation in CREM transgenic mice.","date":"2022","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/34648001","citation_count":21,"is_preprint":false},{"pmid":"16048633","id":"PMC_16048633","title":"CREM activator and repressor isoform expression in human male germ cells.","date":"2005","source":"International journal of andrology","url":"https://pubmed.ncbi.nlm.nih.gov/16048633","citation_count":20,"is_preprint":false},{"pmid":"9846951","id":"PMC_9846951","title":"Regulating the balance between differentiation and apoptosis: role of CREM in the male germ cells.","date":"1998","source":"Journal of molecular medicine (Berlin, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/9846951","citation_count":20,"is_preprint":false},{"pmid":"12397208","id":"PMC_12397208","title":"Novel leader exons of the cyclic adenosine 3',5'-monophosphate response element modulator (CREM) gene, transcribed from promoters P3 and P4, are highly testis-specific in primates.","date":"2002","source":"Molecular human reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/12397208","citation_count":20,"is_preprint":false},{"pmid":"28368536","id":"PMC_28368536","title":"Transcription Factor CREM Mediates High Glucose Response in Cardiomyocytes and in a Male Mouse Model of Prolonged Hyperglycemia.","date":"2017","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/28368536","citation_count":20,"is_preprint":false},{"pmid":"24166353","id":"PMC_24166353","title":"Upregulation of CREM-1 relates to retinal ganglion cells apoptosis after light-induced damage in vivo.","date":"2013","source":"Journal of molecular neuroscience : MN","url":"https://pubmed.ncbi.nlm.nih.gov/24166353","citation_count":20,"is_preprint":false},{"pmid":"12554693","id":"PMC_12554693","title":"Novel regulation of cardiac force-frequency relation by CREM (cAMP response element modulator).","date":"2003","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/12554693","citation_count":20,"is_preprint":false},{"pmid":"7673120","id":"PMC_7673120","title":"An intron facilitates activation of the calspermin gene by the testis-specific transcription factor CREM tau.","date":"1995","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7673120","citation_count":20,"is_preprint":false},{"pmid":"37057373","id":"PMC_37057373","title":"Clear cell tumor with melanocytic differentiation and MITF::CREM translocation.","date":"2023","source":"Journal of cutaneous pathology","url":"https://pubmed.ncbi.nlm.nih.gov/37057373","citation_count":19,"is_preprint":false},{"pmid":"23965306","id":"PMC_23965306","title":"DAZAP1 regulates the splicing of Crem, Crisp2 and Pot1a transcripts.","date":"2013","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/23965306","citation_count":19,"is_preprint":false},{"pmid":"33616852","id":"PMC_33616852","title":"Clear Cell Odontogenic Carcinoma: First Report of Novel EWSR1-CREM Fusion Gene in Case of Long-Term Misdiagnosis.","date":"2021","source":"Head and neck pathology","url":"https://pubmed.ncbi.nlm.nih.gov/33616852","citation_count":19,"is_preprint":false},{"pmid":"14656211","id":"PMC_14656211","title":"The inducible isoform of CREM (inducible cAMP early repressor, ICER) is a repressor of CYP19 rat ovarian promoter.","date":"2003","source":"The Journal of endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/14656211","citation_count":19,"is_preprint":false},{"pmid":"28784605","id":"PMC_28784605","title":"Characterization of the Genetic Program Linked to the Development of Atrial Fibrillation in CREM-IbΔC-X Mice.","date":"2017","source":"Circulation. Arrhythmia and electrophysiology","url":"https://pubmed.ncbi.nlm.nih.gov/28784605","citation_count":19,"is_preprint":false},{"pmid":"16103121","id":"PMC_16103121","title":"The switch in alternative splicing of cyclic AMP-response element modulator protein CREM{tau}2{alpha} (activator) to CREM{alpha} (repressor) in human myometrial cells is mediated by SRp40.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16103121","citation_count":19,"is_preprint":false},{"pmid":"37628737","id":"PMC_37628737","title":"Novel Aspects of cAMP-Response Element Modulator (CREM) Role in Spermatogenesis and Male Fertility.","date":"2023","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/37628737","citation_count":18,"is_preprint":false},{"pmid":"32668333","id":"PMC_32668333","title":"Primary Intracranial Mesenchymal Tumor with EWSR1-CREM Gene Fusion: A Case Report and Literature Review.","date":"2020","source":"World neurosurgery","url":"https://pubmed.ncbi.nlm.nih.gov/32668333","citation_count":17,"is_preprint":false},{"pmid":"25381014","id":"PMC_25381014","title":"Upregulation of CREM/ICER suppresses wound endothelial CRE-HIF-1α-VEGF-dependent signaling and impairs angiogenesis in type 2 diabetes.","date":"2014","source":"Disease models & mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/25381014","citation_count":17,"is_preprint":false},{"pmid":"28973639","id":"PMC_28973639","title":"1,2-Dichloroethane Induces Reproductive Toxicity Mediated by the CREM/CREB Signaling Pathway in Male NIH Swiss Mice.","date":"2017","source":"Toxicological sciences : an official journal of the Society of Toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/28973639","citation_count":17,"is_preprint":false},{"pmid":"28439100","id":"PMC_28439100","title":"Ventral striatal regulation of CREM mediates impulsive action and drug addiction vulnerability.","date":"2017","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/28439100","citation_count":17,"is_preprint":false},{"pmid":"11327716","id":"PMC_11327716","title":"Cloning and expression of activator of CREM in testis in human testicular tissue.","date":"2001","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/11327716","citation_count":17,"is_preprint":false},{"pmid":"26459392","id":"PMC_26459392","title":"The cAMP response element modulator (CREM) regulates TH2 mediated inflammation.","date":"2015","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/26459392","citation_count":17,"is_preprint":false},{"pmid":"18786638","id":"PMC_18786638","title":"Regulation of neural migration by the CREB/CREM transcription factors and altered Dab1 levels in CREB/CREM mutants.","date":"2008","source":"Molecular and cellular neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/18786638","citation_count":17,"is_preprint":false},{"pmid":"7642572","id":"PMC_7642572","title":"The cyclic AMP response elements of the genes for angiotensin converting enzyme and phosphoenolpyruvate carboxykinase (GTP) can mediate transcriptional activation by CREM tau and CREM alpha.","date":"1995","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7642572","citation_count":17,"is_preprint":false},{"pmid":"28807377","id":"PMC_28807377","title":"CREM-transgene mice: An animal model of atrial fibrillation and thrombogenesis.","date":"2017","source":"Thrombosis research","url":"https://pubmed.ncbi.nlm.nih.gov/28807377","citation_count":16,"is_preprint":false},{"pmid":"29529942","id":"PMC_29529942","title":"Abnormal spermatogenesis following sodium fluoride exposure is associated with the downregulation of CREM and ACT in the mouse testis.","date":"2018","source":"Toxicology and industrial health","url":"https://pubmed.ncbi.nlm.nih.gov/29529942","citation_count":16,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":44908,"output_tokens":8547,"usd":0.131465},"stage2":{"model":"claude-opus-4-6","input_tokens":12365,"output_tokens":4852,"usd":0.274687},"total_usd":0.406152,"stage1_batch_id":"msgbatch_011kfMfE81o6CTcyhVUqumuW","stage2_batch_id":"msgbatch_01DTputS6WNkH745x1nVSoBo","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1991,\n      \"finding\": \"CREM encodes multiple isoforms generated by cell-specific alternative splicing that use two alternative downstream DNA-binding domains; all isoforms bind CRE sequences with the same efficiency and specificity as CREB but act as transcriptional repressors/antagonists of cAMP-induced transcription rather than activators.\",\n      \"method\": \"PCR, RNase protection analysis, DNA binding assays, transfection reporter assays\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods in a foundational paper, replicated by subsequent work\",\n      \"pmids\": [\"1847666\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"A developmental switch in CREM splicing occurs during spermatogenesis: premeiotic germ cells express CREM antagonist isoforms at low levels, whereas from pachytene spermatocyte stage onwards an alternative splicing event generates exclusively the CREM tau activator isoform (which contains two glutamine-rich activation domains) that accumulates to very high levels.\",\n      \"method\": \"Northern blot, RT-PCR, transfection reporter assays, cell-type-specific expression analysis\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — orthogonal methods, replicated across multiple subsequent studies\",\n      \"pmids\": [\"1370576\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"CREM antagonists repress cAMP-induced c-fos transcription by binding to the CRE at -60 of the c-fos promoter and heterodimerizing with activator CREB; antisense CREM enhances c-fos basal and cAMP-induced transcription. CREM does not antagonize serum-induced transcription.\",\n      \"method\": \"Transfection reporter assays, antisense CREM expression, EMSA/competition binding\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods with functional and binding validation\",\n      \"pmids\": [\"1647033\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"CREM antagonists bind TRE (AP-1) sites and competitively inhibit c-Jun transcriptional activation without heterodimerizing with Fos or Jun proteins; the phosphorylation domain of CREM is not required for this repression, and the Jun family members JunB, JunD, and v-Jun are also down-regulated.\",\n      \"method\": \"EMSA, transfection reporter assays, in vitro binding assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods demonstrating mechanism of cross-talk repression\",\n      \"pmids\": [\"1429597\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"CREM is inducible by the cAMP signaling pathway from an alternative intronic promoter, generating the ICER (inducible cAMP early repressor) isoform as an early response gene. ICER binds to four tandem CREs in its own (intronic) promoter and represses its own transcription, constituting a negative autoregulatory feedback loop. The subsequent decline in CREM expression requires de novo protein synthesis.\",\n      \"method\": \"Promoter analysis, transfection reporter assays, Northern blot, protein synthesis inhibition experiments\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods; mechanistically foundational and widely replicated\",\n      \"pmids\": [\"8252624\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"FSH (follicle-stimulating hormone) from the pituitary is responsible for the developmental CREM switch from antagonist to activator (CREM tau) during spermatogenesis; hypophysectomy extinguishes CREM tau expression in testis. FSH regulates CREM expression by alternative polyadenylation, resulting in enhanced transcript stability.\",\n      \"method\": \"Hypophysectomy experiments, seasonal spermatogenesis modulation in hamsters, direct hormone administration, Northern blot, RNase protection\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo epistasis via hormone replacement, multiple orthogonal approaches\",\n      \"pmids\": [\"7681549\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"CREM tau is phosphorylated at Ser117 by protein kinase A (PKA) endogenous to germ cells, and this phosphorylation enhances its transactivation potential. CREM tau binds to CREs in promoters of postmeiotic germ cell-specific genes (e.g., RT7), and CREM-specific antibodies block RT7 in vitro transcription.\",\n      \"method\": \"In vitro kinase assays, transfection reporter assays, in vitro transcription with nuclear extracts, antibody supershift/blocking\",\n      \"journal\": \"Molecular endocrinology (Baltimore, Md.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro kinase assay plus in vitro transcription with antibody blocking, multiple orthogonal methods\",\n      \"pmids\": [\"8114765\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"The exon structure of the CREM gene was determined; CREM isoforms heterodimerize in vivo with each other and with CREB. The two alternative DNA-binding domains show distinct CRE binding efficiencies (CREM alpha/CREB heterodimers show stronger binding than CREM beta/CREB heterodimers). A phosphorylation domain plus a single glutamine-rich domain are sufficient for transcriptional activation. A minimal CREM repressor containing only the bZip motif efficiently antagonizes cAMP-induced transcription. Phosphorylation reduces repressor function.\",\n      \"method\": \"Exon mapping, in vivo dimerization assays, EMSA, transfection reporter assays, mutagenesis\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — structure-function mutagenesis combined with binding and transcription assays\",\n      \"pmids\": [\"8458330\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"CREM tau is phosphorylated on multiple serine and threonine residues in vivo. Stimulation by forskolin, TPA, or Ca2+ ionophore enhances Ser117 phosphorylation and transactivation. Casein kinase I and II cooperatively phosphorylate CREM tau on multiple residues, enhancing DNA binding. Multiple kinases can phosphorylate Ser117 in vitro.\",\n      \"method\": \"In vivo phosphorylation labeling, in vitro kinase assays, EMSA, transfection reporter assays\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro and in vivo kinase studies with multiple orthogonal methods\",\n      \"pmids\": [\"8404858\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"The CREM KID (kinase-inducible domain) containing Ser133-equivalent acts as a conditional activator that can enhance activity of other activation domains (Q2, GAL4, GCN4) via phosphorylation by PKA, even when attached to a separate polypeptide bound to an adjacent promoter site. CREM alpha and beta contain KID but function as repressors due to absence of activation domains.\",\n      \"method\": \"Transfection reporter assays with domain swaps and fusion proteins in mammalian cells\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — functional domain dissection with clear mechanistic readout\",\n      \"pmids\": [\"8102791\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"Rhythmic adrenergic signals from the suprachiasmatic nucleus direct circadian ICER expression in the pineal gland via cAMP pathway stimulation, with ICER levels peaking at night and exhibiting a day-night fluctuation.\",\n      \"method\": \"RNase protection, Northern blot, pharmacological manipulation of adrenergic signaling in vivo\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo pharmacological and physiological manipulation with multiple time points\",\n      \"pmids\": [\"8397338\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"p34cdc2 kinase phosphorylates CREM tau on multiple serine and threonine residues both in vivo and in vitro; coexpression of constitutively active p34cdc2 strongly reduces CREM tau trans-activation potential without affecting its DNA binding.\",\n      \"method\": \"In vivo and in vitro phosphorylation assays, EMSA, transfection reporter assays with constitutively active cdc2 mutant\",\n      \"journal\": \"Molecular endocrinology (Baltimore, Md.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro kinase assay plus genetic overexpression functional test\",\n      \"pmids\": [\"8114763\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"DNA bending is induced by CREM (and CREB) binding to CRE flanking sequences. Phosphorylation of CREM or CREB enhances the angle of DNA bending. No differences in bending were detected between CREM proteins with the two alternative DNA-binding domains.\",\n      \"method\": \"Permuted binding site gel retardation assay with bacterially expressed proteins\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — single lab, direct biochemical measurement of DNA bending\",\n      \"pmids\": [\"8290258\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"CREM alpha can form non-functional heterodimers with CREB that prevent gene activation, but when selectively forced into CREB-CREM alpha heterodimers via engineered leucine zippers, CREM alpha contributes to PKA-mediated gene activation in a phosphorylation-dependent manner. Thus the inhibitory function of CREM alpha depends on whether it is in a homodimer or heterodimer context and on phosphorylation state.\",\n      \"method\": \"Leucine zipper domain engineering to force defined dimer pairs, in vivo transcription assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — elegant domain engineering plus functional transcription assays\",\n      \"pmids\": [\"7961842\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"A CREM isoform (CREM delta C-G) expressed in elongated spermatids lacks exons encoding the PKA phosphorylation domain and glutamine-rich activation domains but retains the bZIP DNA-binding domain; it binds CREs, competitively inhibits CREB and CREM CRE binding, and inhibits CRE-driven reporter transcription.\",\n      \"method\": \"RT-PCR from germ cells, EMSA, transfection reporter assays, immunostaining with CREM antiserum\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — protein characterization with binding and functional assays\",\n      \"pmids\": [\"7809053\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"TSH induces ICER (the inducible CREM isoform) in rat thyroid gland and FRTL-5 cells; ICER binds a CRE-like sequence in the TSH receptor (TSH-R) promoter and represses its expression. The kinetics of ICER induction mirrors TSH-R mRNA down-regulation, identifying ICER as a mediator of homologous long-term desensitization of the TSH receptor.\",\n      \"method\": \"Northern blot, EMSA, transfection reporter assays with ICER overexpression, in vivo TSH administration\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo and in vitro experiments with binding and functional validation\",\n      \"pmids\": [\"7568187\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"A 111-bp first intron of the calspermin gene is required for CREM tau-mediated transcriptional enhancement via CRE motifs; deletion or inversion abolishes CREM tau stimulation; the intron functions as an orientation-dependent, position-independent regulatory element facilitating CREM tau activity.\",\n      \"method\": \"Deletion/inversion mutagenesis, footprinting, linker scanning, transfection reporter assays with CREM tau\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — systematic mutagenesis with clear mechanistic conclusion\",\n      \"pmids\": [\"7673120\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"CREM-deficient mice (generated by homologous recombination) show postmeiotic arrest at the first step of spermiogenesis, complete absence of late spermatids, absence of spermatozoa, increased germ cell apoptosis (~10-fold), and loss of postmeiotic germ cell-specific gene expression. CREM is thus essential for spermiogenesis.\",\n      \"method\": \"Homologous recombination knockout, histology, TUNEL apoptosis assay, RT-PCR/Northern blot for target gene expression\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined cellular and molecular phenotype, replicated by independent lab simultaneously\",\n      \"pmids\": [\"8600390\", \"8600391\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"CREM-null mice show dramatic increase in serotonin N-acetyltransferase (NAT) expression in pineal gland. ICER binds a CRE site in the NAT promoter and represses NAT transcription in transfection assays, establishing CREM/ICER as a central regulator of circadian melatonin synthesis.\",\n      \"method\": \"CREM knockout mice, Northern blot, EMSA, transfection reporter assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO phenotype validated by EMSA and reporter assays\",\n      \"pmids\": [\"8943074\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"The transcriptional response of the CREM gene to adrenergic stimulation is modulated by prior photoperiod (circadian memory): the balance between positive regulator CREB and negative regulator ICER determines whether the CREM gene is subsensitive or supersensitive to cAMP induction depending on night length.\",\n      \"method\": \"In vivo photoperiod manipulation, Northern blot analysis, quantification of CREB vs. ICER levels\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo physiological epistasis with molecular analysis\",\n      \"pmids\": [\"8609995\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"CREM transcription factor coordinates hepatocyte proliferation timing after partial hepatectomy; CREM-/- mice show reduced DNA synthesis, fewer mitotic cells, delayed S-phase entry, and deregulated expression of cyclins A, B, D1, E, cdc2, c-fos, and tyrosine aminotransferase compared to wild-type.\",\n      \"method\": \"Partial hepatectomy in CREM-/- mice, BrdU incorporation, histone H3 phosphorylation, RT-PCR, immunostaining\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO with specific proliferation phenotype and multiple molecular readouts\",\n      \"pmids\": [\"9851970\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"ACT (activator of CREM in testis), a LIM-only protein, was identified via two-hybrid screen as a testis-specific binding partner of CREM. ACT has intrinsic transcriptional activation function and strongly stimulates CREM transcriptional activity in yeast and mammalian cells in a phosphorylation-independent manner, bypassing the classical requirement for Ser117 phosphorylation and CBP interaction.\",\n      \"method\": \"Yeast two-hybrid screen, co-immunoprecipitation, transfection reporter assays in yeast and mammalian cells\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — two-hybrid plus reciprocal co-IP plus functional reporter assays, replicated in subsequent studies\",\n      \"pmids\": [\"10086359\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"CREB/CREM complex binds the -180 site of the IL-2 promoter in anergic T cells; induction of anergy by prolonged TCR stimulation increases CREB/CREM binding at this site; mutation of the -180 site that specifically reduces CREB/CREM binding decreases susceptibility to anergy-induced IL-2 repression.\",\n      \"method\": \"EMSA, gel supershift assays, reporter constructs with site-specific mutations, T cell anergy induction\",\n      \"journal\": \"Journal of immunology (Baltimore, Md. : 1950)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — binding and functional mutant reporter assays in physiologically relevant T cell anergy system\",\n      \"pmids\": [\"10586058\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"CREM-null mice show dramatically increased locomotion, equal locomotor activity throughout the circadian cycle (loss of circadian locomotor variation), and decreased anxiety-like behavior in two behavioral tests, demonstrating CREM's specific role in behavioral and circadian control.\",\n      \"method\": \"CREM-null mice, open field locomotor tests, anxiety behavioral models (elevated plus maze, light-dark box), circadian activity monitoring\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined behavioral phenotypes\",\n      \"pmids\": [\"10570204\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"CREMtau from germ cell nuclear extracts binds a conserved CYP51-CRE2 element in the CYP51 proximal promoter and activates CYP51 transcription in spermatids; CREM-/- mice lack abundant germ cell-specific CYP51 mRNAs while somatic CYP51 transcripts are unaffected, demonstrating CREM-dependent regulation of a cholesterogenic gene specifically in haploid germ cells.\",\n      \"method\": \"EMSA with germ cell vs. somatic nuclear extracts, CREM KO mice, Northern blot for CYP51 transcripts, promoter reporter assays\",\n      \"journal\": \"Molecular endocrinology (Baltimore, Md.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO mouse phenotype combined with binding and reporter assays\",\n      \"pmids\": [\"10551787\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"CREM interacts with the general transcription factor TFIIA (identified by two-hybrid screen from testis cDNA library and confirmed by co-immunoprecipitation); this interaction is restricted to activator isoforms of CREM and does not require Ser117 phosphorylation. CREM does not interact with testis-specific TFIIAtau-ALF. CREM and TFIIA colocalize in spermatocytes and spermatids.\",\n      \"method\": \"Yeast two-hybrid, co-immunoprecipitation, immunofluorescence co-localization\",\n      \"journal\": \"Molecular endocrinology (Baltimore, Md.)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — two-hybrid confirmed by co-IP and co-localization, single lab\",\n      \"pmids\": [\"14512522\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"CREM-null mice display markedly depressed cardiac force-frequency relationship (reduced contractile augmentation and relaxation shortening at faster heart rates) associated with decreased total and serine-phosphorylated phospholamban protein and increased protein phosphatase-1 (PP1) activity, without changes in beta-adrenergic signaling, identifying a novel role for CREM in regulating PP1 activity and cardiac function.\",\n      \"method\": \"In vivo pressure-volume loops, echocardiography, PP1 activity assay, Western blot, isoproterenol dose-response in CREM-/- mice\",\n      \"journal\": \"FASEB journal : official publication of the Federation of American Societies for Experimental Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with specific physiological and biochemical phenotypes\",\n      \"pmids\": [\"12554693\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"SRp40, an SR protein splicing factor, regulates the switch in CREM alternative splicing from CREMtau2alpha (activator) to CREMalpha (repressor) in human myometrial cells during pregnancy; SRp40 acts through multiple exonic splicing enhancer (ESE) motifs in alternatively spliced CREM exons.\",\n      \"method\": \"Transient transfection of splicing factor constructs, in vitro splicing assays, EMSA for SRp40-ESE binding, minigene deletion analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods identifying splicing mechanism\",\n      \"pmids\": [\"16103121\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"CREMtau and Tisp40 form a heterodimer that binds CRE (but not UPRE) elements; Tisp40 dramatically enhances the binding of CREMtau to CRE sequences. The Tisp40DeltaTM-CREMtau heterodimer recruits the histone chaperone HIRA to CRE sites. Tisp40alpha mRNA is a direct transcriptional target of CREM, as confirmed by ChIP.\",\n      \"method\": \"Co-immunoprecipitation, EMSA, ChIP, transfection reporter assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — co-IP, binding assays, ChIP and reporter assays in combination\",\n      \"pmids\": [\"16595651\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"SPAG8 (sperm associated antigen 8), a testis-specific protein, associates with ACT (the CREM coactivator) and enhances ACT-mediated CREMtau transcriptional activation by strengthening ACT binding to CREMtau.\",\n      \"method\": \"Co-immunoprecipitation, pulldown assays, transfection reporter assays\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — co-IP plus reporter assay, single lab\",\n      \"pmids\": [\"20488182\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"ChIP-seq mapping in round spermatids shows CREM occupies more than 6700 genomic loci in a highly cell-specific manner, including promoters of spermiogenesis-specific genes and genes expressed in other cell types, indicating remarkably open chromatin in spermatids. Only a small subset of these occupied loci show expression changes in CREM knockout spermatids.\",\n      \"method\": \"Chromatin immunoprecipitation coupled to sequencing (ChIP-seq) in round spermatids; CREM KO comparison\",\n      \"journal\": \"BMC genomics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genome-wide ChIP-seq in physiologically relevant primary tissue combined with KO comparison\",\n      \"pmids\": [\"20920259\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"A novel intronic CREM promoter (P2) upstream of exon 2 harbors functional TATA-box and AP-1 binding sites; T cell activation via CD3/CD28 or PMA/ionomycin enhances P2 promoter activity. In SLE T cells, reduced c-Fos content prevents AP-1-dependent P2 activation; CREM trans-represses c-fos, establishing an autoregulatory feedback between CREM and AP-1.\",\n      \"method\": \"DNA binding assays (EMSA), chromatin immunoprecipitation, reporter assays, siRNA, T cell stimulation assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods identifying novel promoter and autoregulatory mechanism\",\n      \"pmids\": [\"21757709\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"CREMalpha orchestrates epigenetic silencing of the CD8 gene cluster in SLE T cells by recruiting DNA methyltransferase DNMT3a and histone methyltransferase G9a, driving expansion of CD3+CD4-CD8- double-negative T cells.\",\n      \"method\": \"Co-immunoprecipitation, ChIP, siRNA knockdown, flow cytometry, reporter assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP and co-IP demonstrate direct epigenetic mechanism with functional consequence\",\n      \"pmids\": [\"24297179\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"DAZAP1 regulates alternative splicing of CREM pre-mRNA; DAZAP1 promotes inclusion of CREM exon 4 by binding regulatory sequences in CREM intron 3. Loss of DAZAP1 results in aberrant CREM splicing in mouse testis.\",\n      \"method\": \"Microarray exon profiling, splicing reporter minigene assays, DAZAP1 mutant binding studies, DAZAP1-null mouse model\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods identifying splicing regulatory mechanism\",\n      \"pmids\": [\"23965306\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"CaMK4 is required for Th17 cell differentiation; CaMK4 activates CREMalpha, which in turn promotes IL-17 transcription and activates the AKT/mTOR pathway. Genetic or pharmacological inhibition of CaMK4 decreases CREMalpha activation, reducing IL17A and IL17F mRNA in human SLE T cells.\",\n      \"method\": \"Genetic CaMK4 knockout, pharmacological inhibition, siRNA in human and mouse T cells, Th17 differentiation assays, cytokine measurements, reporter assays\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO plus pharmacological inhibition plus siRNA in human cells, multiple readouts\",\n      \"pmids\": [\"24667640\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Transgenic cardiac expression of CREM repressor isoform CREM-IbDeltaC-X leads to increased NCX-mediated Ca2+ transport, enhanced NCX1 protein levels, increased INCX, decreased Ito and KChIP2, action potential prolongation, increased early afterdepolarizations, and ventricular extrasystoles, demonstrating CREM repressor's role in arrhythmogenic cardiac remodeling.\",\n      \"method\": \"Patch clamp, calcium imaging, immunoblotting, RT-PCR, transgenic mouse model\",\n      \"journal\": \"Basic research in cardiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — transgenic model with multiple electrophysiological and molecular readouts\",\n      \"pmids\": [\"26818679\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"CREM is induced in CAR-NK cells by both CAR activation and IL-15 signaling via the PKA-CREB signaling pathway (downstream of ITAM signaling). CREM deletion enhances CAR-NK cell effector function in vitro and in vivo and increases resistance to tumor-induced immunosuppression. CREM exerts its regulatory functions through epigenetic reprogramming of CAR-NK cells.\",\n      \"method\": \"Transcriptomic analysis, CREM deletion via genetic editing, in vitro cytotoxicity assays, in vivo tumor models, epigenetic profiling\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic deletion with in vitro and in vivo functional readouts plus mechanistic pathway elucidation\",\n      \"pmids\": [\"40468083\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"ICER (inducible CREM isoform) binds a CRE-like sequence in the CYP19 (aromatase) ovarian promoter; ICER overexpression suppresses FSH-induced CYP19 promoter activity in granulosa cells and R2C cells; stable antisense ICER blocks 24-48h cAMP-induced downregulation, identifying ICER/CREM as a mediator of LH-induced aromatase downregulation during luteinization.\",\n      \"method\": \"EMSA with supershift, transfection reporter assays, stable ICER overexpression and antisense cell lines\",\n      \"journal\": \"The Journal of endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — binding assays plus gain/loss of function reporter experiments\",\n      \"pmids\": [\"14656211\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CREM is a modular bZIP transcription factor that generates multiple isoforms—repressors and activators—by cell-specific alternative splicing and alternative promoter usage; repressor isoforms (CREM alpha/beta/gamma, ICER) compete with CREB at CRE and TRE sites to antagonize cAMP-induced transcription, while the activator isoform CREMtau is phosphorylated at Ser117 by PKA (and other kinases) to recruit CBP, or alternatively bypasses phosphorylation by associating with the testis-specific LIM-only coactivator ACT (which also recruits TFIIA and HIRA), enabling phosphorylation-independent transcriptional activation of postmeiotic germ cell genes essential for spermiogenesis; ICER is itself transcribed from an intronic cAMP-inducible promoter and autorepresses its own expression to generate negative feedback loops governing circadian rhythms, hormonal desensitization, and transient cAMP responses in diverse tissues including pineal gland, thyroid, liver, heart, and immune cells.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"CREM is a modular bZIP transcription factor that generates functionally antagonistic isoforms—repressors and activators—through cell-specific alternative splicing, alternative promoter usage, and regulated polyadenylation, enabling it to serve as a master switch governing cAMP-responsive gene expression in spermatogenesis, circadian rhythmicity, immune cell function, and cardiac physiology [PMID:1847666, PMID:1370576, PMID:8252624, PMID:8397338, PMID:8600390]. Repressor isoforms (CREMα/β/γ and the cAMP-inducible ICER) compete with CREB at CRE and TRE sites to antagonize transcription and create negative autoregulatory feedback loops that mediate hormonal desensitization and circadian oscillations, while in T cells CREMα recruits DNMT3a and G9a to epigenetically silence target loci such as the CD8 cluster [PMID:8252624, PMID:1429597, PMID:24297179]. The activator isoform CREMτ, induced in postmeiotic germ cells by FSH-driven alternative splicing, is phosphorylated at Ser117 by PKA and other kinases to recruit CBP, but can also bypass phosphorylation-dependent activation through association with the testis-specific LIM-only coactivator ACT and the general transcription factor TFIIA, driving expression of spermiogenesis genes whose loss in CREM-null mice causes complete postmeiotic arrest and male infertility [PMID:8114765, PMID:10086359, PMID:14512522, PMID:8600390]. CREM deletion also enhances CAR-NK cell effector function through epigenetic reprogramming, identifying CREM as a negative regulator of immune cytotoxicity [PMID:40468083].\",\n  \"teleology\": [\n    {\n      \"year\": 1991,\n      \"claim\": \"The discovery that a single gene generates multiple CRE-binding repressor isoforms via alternative splicing established CREM as an antagonist of cAMP-induced transcription, revealing that the cAMP pathway has a dedicated transcriptional brake distinct from CREB.\",\n      \"evidence\": \"PCR, RNase protection, DNA binding assays, and reporter assays characterizing CREM isoforms and their repressor activity on CRE-driven promoters\",\n      \"pmids\": [\"1847666\", \"1647033\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Activator isoforms not yet identified\", \"In vivo relevance of repression not demonstrated\", \"Structural basis of repressor vs. activator function unknown\"]\n    },\n    {\n      \"year\": 1992,\n      \"claim\": \"Identification of CREMτ as an activator isoform and demonstration that a developmental splicing switch converts CREM from repressor to activator during spermatogenesis revealed how a single locus can toggle between opposing transcriptional outputs in a tissue-specific manner.\",\n      \"evidence\": \"RT-PCR, Northern blot, and reporter assays showing stage-specific CREMτ accumulation in postmeiotic germ cells; separate demonstration that CREM repressors bind TRE sites to inhibit Jun-mediated transcription\",\n      \"pmids\": [\"1370576\", \"1429597\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Upstream signal driving the splicing switch unknown\", \"Target genes of CREMτ in spermatids not identified\", \"Mechanism by which CREMτ activates transcription not resolved\"]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"Multiple advances in 1993 defined the core activation mechanism: CREMτ is phosphorylated at Ser117 by PKA and other kinases to create a conditional activation domain (KID), ICER was identified as a cAMP-inducible autorepressive isoform from an intronic promoter, and circadian ICER oscillation was linked to adrenergic signaling in the pineal gland—together establishing the molecular logic of CREM's dual activator/autorepressor feedback circuit.\",\n      \"evidence\": \"In vitro kinase assays, in vivo phosphorylation labeling, domain-swap reporter assays, ICER promoter analysis, Northern blot time courses in pineal gland, pharmacological manipulation of adrenergic signaling\",\n      \"pmids\": [\"8114765\", \"8404858\", \"8102791\", \"8252624\", \"8397338\", \"8114763\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Coactivator recruited by phospho-KID not identified\", \"Whether ICER feedback is sufficient for circadian rhythms not tested genetically\", \"Contribution of casein kinases vs. PKA vs. cdc2 to CREM function in vivo unclear\"]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"FSH was identified as the pituitary hormone responsible for the CREMτ splicing switch in spermatogenesis, acting through alternative polyadenylation to stabilize CREMτ transcripts—connecting an endocrine axis to a post-transcriptional gene regulation event.\",\n      \"evidence\": \"Hypophysectomy abolishes CREMτ in testis; direct FSH administration restores it; seasonal spermatogenesis in hamsters as a natural model\",\n      \"pmids\": [\"7681549\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Splicing factors mediating the FSH-driven switch not identified\", \"Whether polyadenylation change is direct or indirect unknown\"]\n    },\n    {\n      \"year\": 1994,\n      \"claim\": \"Structure–function studies showed that CREM's repressor versus activator output depends on modular domain composition and dimerization context: a minimal bZIP repressor lacking activation domains antagonizes CRE-driven transcription, while forced CREB–CREMα heterodimers can activate in a phosphorylation-dependent manner, demonstrating that dimer identity dictates functional outcome.\",\n      \"evidence\": \"Engineered leucine zipper domains to force defined dimer pairs, reporter assays, phosphorylation mutants; identification of spermatid-specific CREMδC-G repressor isoform\",\n      \"pmids\": [\"7961842\", \"7809053\", \"8290258\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Crystal structure of CREM dimers not determined\", \"Relative abundance of different dimers in vivo unknown\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"CREM knockout mice revealed that CREM is essential for spermiogenesis (complete postmeiotic arrest, loss of spermatozoa) and for circadian regulation of melatonin synthesis (derepression of NAT), establishing non-redundant in vivo functions for both the activator and ICER repressor arms.\",\n      \"evidence\": \"Homologous recombination knockout in two independent labs; histology, TUNEL, RT-PCR for target genes; ICER–CRE binding and NAT derepression in KO pineal\",\n      \"pmids\": [\"8600390\", \"8600391\", \"8943074\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Which of the >6000 CREM-occupied loci are functionally required for spermiogenesis unknown\", \"Redundancy with CREB in non-testis tissues not systematically tested\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Demonstration that the balance between CREB and ICER at the CREM intronic promoter encodes photoperiod history ('circadian memory') revealed how the same autoregulatory loop can produce different transcriptional responses depending on prior light exposure.\",\n      \"evidence\": \"In vivo photoperiod manipulation with quantification of CREB vs. ICER protein levels and CREM transcriptional responsiveness\",\n      \"pmids\": [\"8609995\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Chromatin state changes at the ICER promoter across photoperiods not examined\", \"Whether this memory mechanism operates outside the pineal gland unknown\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"CREM was shown to coordinate hepatocyte proliferation timing after partial hepatectomy, with CREM-null mice exhibiting delayed S-phase entry and deregulated cyclin/cdc2 expression, extending CREM's functional repertoire beyond endocrine tissues to regenerative cell cycle control.\",\n      \"evidence\": \"Partial hepatectomy in CREM-/- mice with BrdU incorporation, histone H3 phosphorylation, RT-PCR for cell cycle genes\",\n      \"pmids\": [\"9851970\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct vs. indirect regulation of cyclin genes by CREM not distinguished\", \"Whether ICER or CREMτ mediates the hepatic phenotype unclear\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Discovery of ACT, a testis-specific LIM-only coactivator that stimulates CREMτ transcription without requiring Ser117 phosphorylation or CBP, revealed a phosphorylation-independent activation pathway explaining how CREMτ can activate postmeiotic genes even in the absence of active PKA signaling.\",\n      \"evidence\": \"Yeast two-hybrid screen, co-immunoprecipitation, reporter assays in yeast and mammalian cells showing phosphorylation-independent activation\",\n      \"pmids\": [\"10086359\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of ACT–CREMτ interaction unknown\", \"Whether ACT is the predominant coactivator in vivo or works alongside CBP unclear\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"CREB/CREM binding at the IL-2 promoter CRE was shown to mediate T cell anergy, establishing CREM as a regulator of adaptive immune tolerance and linking it to autoimmune pathology.\",\n      \"evidence\": \"EMSA supershift, site-directed mutagenesis of the -180 CRE in IL-2 reporter, anergy induction in T cells\",\n      \"pmids\": [\"10586058\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Which CREM isoform predominates in anergic T cells not determined\", \"In vivo contribution of CREM to anergy vs. other CRE-binding factors not resolved\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Identification of TFIIA as a direct CREMτ-interacting partner in testis, and ICER-mediated repression of aromatase (CYP19) and TSH receptor, expanded the known cofactor repertoire and target gene landscape of CREM across reproductive and endocrine tissues.\",\n      \"evidence\": \"Two-hybrid screen, co-IP, co-localization in spermatocytes/spermatids for TFIIA; EMSA and reporter assays for ICER on CYP19 and TSH-R promoters\",\n      \"pmids\": [\"14512522\", \"14656211\", \"7568187\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequence of TFIIA interaction for specific target gene expression not shown in vivo\", \"Whether TFIIA and ACT cooperate or compete for CREMτ binding unclear\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Identification of SRp40 as a splicing factor that regulates the CREM activator-to-repressor switch via exonic splicing enhancers provided the first molecular mechanism for tissue-specific CREM isoform choice outside the germline.\",\n      \"evidence\": \"Splicing factor overexpression, in vitro splicing, EMSA for SRp40-ESE binding, minigene analysis in human myometrial cells\",\n      \"pmids\": [\"16103121\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether SRp40 also operates in testis or other tissues not tested\", \"Upstream signals regulating SRp40 activity on CREM exons unknown\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Demonstration that CREMτ heterodimerizes with Tisp40 to enhance CRE binding and recruit the histone chaperone HIRA added an epigenetic dimension to CREMτ's activation mechanism in spermatids.\",\n      \"evidence\": \"Co-IP, EMSA showing enhanced binding, ChIP confirming Tisp40 is a direct CREM target\",\n      \"pmids\": [\"16595651\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether HIRA recruitment leads to specific histone variant deposition at CREMτ target genes not shown\", \"Functional redundancy between ACT and Tisp40 pathways untested\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Genome-wide ChIP-seq in round spermatids revealed that CREM occupies over 6700 loci—far exceeding the number of expression-dependent targets—indicating that CREM binding in spermatids occurs across broadly open chromatin and that occupancy alone is insufficient for transcriptional regulation.\",\n      \"evidence\": \"ChIP-seq in purified round spermatids with comparison to CREM-KO expression changes\",\n      \"pmids\": [\"20920259\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"What distinguishes functionally productive CREM binding from passive occupancy remains unknown\", \"Cofactor co-occupancy at regulated vs. non-regulated sites not mapped\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"CREMα was shown to recruit DNMT3a and G9a to epigenetically silence the CD8 locus in SLE T cells, mechanistically explaining the expansion of pathogenic double-negative T cells and establishing CREM as an epigenetic effector in autoimmunity; separately, DAZAP1 was identified as a splicing regulator of CREM exon inclusion in testis.\",\n      \"evidence\": \"ChIP, co-IP, siRNA, flow cytometry in SLE T cells for epigenetic silencing; DAZAP1-null mouse and minigene assays for splicing\",\n      \"pmids\": [\"24297179\", \"23965306\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether CREMα recruits DNMT3a/G9a at other immune loci not tested genome-wide\", \"Contribution of DAZAP1 vs. SRp40 to CREM splicing in different tissues not compared\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"CaMK4 was identified as an upstream kinase that activates CREMα to drive IL-17 transcription and Th17 differentiation, positioning CREM within the CaMK4–AKT/mTOR signaling axis relevant to SLE pathogenesis.\",\n      \"evidence\": \"CaMK4 knockout, pharmacological inhibition, siRNA in human SLE T cells, Th17 differentiation assays\",\n      \"pmids\": [\"24667640\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific CREMα phosphorylation site(s) targeted by CaMK4 not mapped\", \"Whether CaMK4–CREM axis operates in other Th subsets not examined\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Transgenic cardiac expression of a CREM repressor isoform caused arrhythmogenic remodeling with action potential prolongation, early afterdepolarizations, and altered calcium handling, demonstrating that CREM repressor activity directly shapes cardiac electrophysiology.\",\n      \"evidence\": \"Transgenic mouse, patch clamp, calcium imaging, immunoblotting for NCX1, KChIP2, phospholamban\",\n      \"pmids\": [\"26818679\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Which CREM target genes mediate the ion channel remodeling not identified by ChIP\", \"Whether endogenous CREM repressor isoforms reach pathological levels in human heart disease unknown\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"CREM was identified as a negative regulator of CAR-NK cell cytotoxicity: CREM is induced downstream of CAR/ITAM and IL-15/PKA-CREB signaling, and its deletion enhances effector function and resistance to tumor-induced immunosuppression through epigenetic reprogramming, opening a new immunotherapy-relevant axis.\",\n      \"evidence\": \"CREM deletion by genetic editing in CAR-NK cells, in vitro cytotoxicity, in vivo tumor models, transcriptomic and epigenetic profiling\",\n      \"pmids\": [\"40468083\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific epigenetic targets reprogrammed by CREM deletion in NK cells not fully characterized\", \"Whether CREM also limits CAR-T cell function through similar mechanisms not tested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include: what distinguishes functionally productive CREM occupancy from passive binding at the thousands of open-chromatin sites in spermatids; how the multiple coactivators (ACT, TFIIA, HIRA, CBP) are coordinated at specific target promoters; and whether the CREM-mediated epigenetic silencing mechanism discovered in SLE T cells operates genome-wide across immune cell subsets.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structural model of CREMτ with any coactivator\", \"Genome-wide cofactor co-occupancy map at CREM-bound sites lacking\", \"Therapeutic targeting of specific CREM isoforms not achieved\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 2, 3, 6, 7, 14, 22, 28, 30]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 1, 4, 6, 9, 17, 32, 34, 36]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 6, 25, 30, 32]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:R-HSA-74160\", \"supporting_discovery_ids\": [0, 1, 4, 6, 9, 17, 32]},\n      {\"term_id\": \"GO:R-HSA-162582\", \"supporting_discovery_ids\": [4, 8, 10, 19, 34, 36]},\n      {\"term_id\": \"GO:R-HSA-1474165\", \"supporting_discovery_ids\": [1, 5, 6, 17, 24]},\n      {\"term_id\": \"GO:R-HSA-168256\", \"supporting_discovery_ids\": [22, 32, 34, 36]},\n      {\"term_id\": \"GO:R-HSA-4839726\", \"supporting_discovery_ids\": [28, 32]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"CREB1\",\n      \"ACT\",\n      \"TFIIA\",\n      \"DNMT3A\",\n      \"G9A\",\n      \"HIRA\",\n      \"Tisp40\",\n      \"CBP\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}